Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05147701 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 17, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 3 to 2
    • Eligibility criteria expanded, about 3 words
    • Study description expanded, about 2 words
    • Study title shortened, about 1 word
    v5
  2. Study description expanded, about 25 wordsv4
  3. Study sites: 1 to 3
    • Start date changed from estimate of Jan 2022 to Feb 1, 2022
    v3
  4. Site contact updatedv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of non-arteritic ischemic optic neuropathy
Trial Details
NCT Number NCT05147701
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions
(from sponsor)		 Eye Diseases, Retinitis Pigmentosa, Diabetic Retinopathy, Macular Degeneration, Traumatic Optic Neuropathy, Optic Atrophy
Related terms Diabetic Retinopathy, Eye Diseases, Macular Degeneration, Optic Atrophy, Optic Nerve Injuries, Retinitis Pigmentosa
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov